| pubmed-article:12720128 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12720128 | lifeskim:mentions | umls-concept:C0024419 | lld:lifeskim |
| pubmed-article:12720128 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:12720128 | lifeskim:mentions | umls-concept:C0079904 | lld:lifeskim |
| pubmed-article:12720128 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:12720128 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:12720128 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12720128 | pubmed:dateCreated | 2003-4-29 | lld:pubmed |
| pubmed-article:12720128 | pubmed:abstractText | Indolent lymphoproliferative disorders such as Waldenstrom's macroglobulinemia (WM) are characterized by defective apoptosis, which leads to progressive accumulation of slowly dividing neoplastic lymphocytes. Activation of nuclear factor kappa B (NFkappaB) is considered to have a central pathogenic role in some hematological malignancies, including multiple myeloma, Hodgkin's disease, and extranodal marginal zone lymphoma (ENMZL). NFkappaB activation may inhibit apoptosis through the transactivation of genes such as Bcl-2 and may therefore be an important mechanism in indolent lymphoproliferative disorders, including WM. In order to assess this potential mechanism, we used immunohistochemistry to determine the presence and subcellular localisation of the major NFkappaB subunits p50 and p65. Nuclear staining of NFkappaB subunits (indicative of activation) was not seen in any of the 40 cases examined. Thirty-seven (95%) cases showed cytoplasmic positivity for both p50 and p65 and one case demonstrated cytoplasmic staining for p65 alone, while the two remaining cases showed complete absence of staining. We would therefore conclude that NFkappaB activation is not a feature of WM and that alternative mechanisms of apoptosis inhibition should be investigated in this disorder. | lld:pubmed |
| pubmed-article:12720128 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12720128 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12720128 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12720128 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12720128 | pubmed:issn | 0093-7754 | lld:pubmed |
| pubmed-article:12720128 | pubmed:author | pubmed-author:OwenRoger GRG | lld:pubmed |
| pubmed-article:12720128 | pubmed:author | pubmed-author:BarransSharon... | lld:pubmed |
| pubmed-article:12720128 | pubmed:author | pubmed-author:JackAndrew... | lld:pubmed |
| pubmed-article:12720128 | pubmed:author | pubmed-author:LeitchDerekD | lld:pubmed |
| pubmed-article:12720128 | pubmed:copyrightInfo | Copyright 2003 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:12720128 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12720128 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:12720128 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12720128 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12720128 | pubmed:pagination | 161-4 | lld:pubmed |
| pubmed-article:12720128 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:meshHeading | pubmed-meshheading:12720128... | lld:pubmed |
| pubmed-article:12720128 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12720128 | pubmed:articleTitle | Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation. | lld:pubmed |
| pubmed-article:12720128 | pubmed:affiliation | HMDS Laboratory, The General Infirmary at Leeds, Leeds, UK. | lld:pubmed |
| pubmed-article:12720128 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12720128 | lld:pubmed |
